Biosafety Tips

Centers for Disease Control and Prevention. (2003). Smallpox vaccine adverse events coordinators; National Immunization Program. Update: Adverse events following civilian smallpox vaccination—United States. Morbidity and Mortality Weekly Report, 53(05), 106–107. Available at www.cdc.gov/mmwr/preview/mmwrhtml/mm5234a4.htm.

Centers for Disease Control and Prevention. (2001). Vaccinia (smallpox) vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 50, (RR10), 1–25. Available at www.cdc.gov/mmwr/preview/mmwrhtml/rr5010a1.htm.

Health and Safety Executive Advisory Committee on Genetic Modification. (2005). Incidents-lessons to be learnt—Accidental infection with vaccinia virus. Newsletter, 32. Available at www.hse.gov.uk/biosafety/gmo/acgm/acgm32/paper8.htm.

Jones L. , Ristow S. , Yilma T. , Moss B. (1986). Accidental human vaccination with vaccinia virus expressing nucleoprotein gene. Nature, 319, 543.

Kost T. , Condreay P. , Mickelson C. (2001). Bio-safety and viral gene transfer vectors. In Fleming D. , Hunt D. (Eds.), Biological safety principles and practices (3rd ed.) (pp. 579–597). Washington, DC: ASM Press.

Loeb M. , Zando I. , Orvidas M. C. , Bialachowski A. , Groves D. , Mahoney J. (2003). Canada communicable disease report, 29(15), 134–136. Available at www.phac-aspc.gc.ca/publicat/ccdr-rmtc/03vol29/dr2915eb.html.

Mempel M. , Isa G. , Klugbauer N. , Meyer H. , Wildi G. , Ring J. , Hofmann F. , Hofmann H. (2003). Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulat-ing construct. The Journal of Investigative Dermatology, 120, 356–358.

Moussatche N. , Tuyama M. , Kato S. E. M. , Castro P. V. , Njaine B. , Peralta J. M. , Damasco C. R. A. , Barroso P. F. (2003). Accidental infection of laboratory worker with vaccinia virus. Emerging Infectious Diseases, 9(6), 724–726. Available at www.cdc.gov/ncidod/EID/vol9no6/02–0732.htm.

Openshaw P. J. M. , Alwan W. H. , Cherrie A. H. , Record F. M. (1991). Accidental infection of laboratory worker with recombinant vaccinia virus. Lancet, 338, 459.

Rocke T. E. , Dein F. J. , Fuchsberger M. , Fox B. C. , Stinchcomb D. T. , Osorio J. E. (2004). Limited infection upon human exposure to a recombinant raccoon pox vaccine vector. Vaccine, 22, 2757–2760.

Rupprecht C. E. , Blass L. , Smith K. , Orciari L. A. , Niezgoda M. , Whitfield S. G. , Gibbons R.V. , Guerra M. , Hanlon C. A. (2001). Human infection due to recombinant vaccinia-rabies glycoprotein virus. New England Journal of Medicine, 345, 582–586.

Rusnak J. M. , Kortepeter M. G. , Hawley R. J. , Anderson A. O. , Boudreau E , Fitzen E. (2004). Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers. Biosecur Bioterror, 2(4), 281–293.

Upfal M. J. , Cinti S. (2004) Adverse cardiac events after smallpox vaccination. Emerging Infectious Diseases, 10(5), 961–962. Available at www.cdc.gov/ncidod/EID/vol10no5/03–0967_04–0235.htm.

Wlodaver C. G. , Palumbo C. G. , Waner J. L. (2004). Laboratory-acquired vaccinia infection. Journal of Clinical Virology, 29, 167–170.